Pfizer Inc
PFE
Company Profile
Business description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Contact
66 Hudson Boulevard East
New York NY 10001-2192
USAT: +1 212 733-2323
E: IR@pfizer.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
88,000
Pfizer Inc News & Analysis
stocks
3 cheap Wide Moat stocks in a divided industry
All but a couple of shares in this industry have sold off. Our analysts think these three high quality companies have fallen too far.
stocks
Obesity drug stocks: Where to invest now
Eli Lilly and Novo Nordisk have staged big rallies. Here’s how investors can approach this potentially huge opportunity.
stocks
3 undervalued US value shares with moats
Value continues to underperform but it may be a function of how we think about the investing style.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,206.10 | 72.70 | 0.89% |
| CAC 40 | 7,724.32 | 97.19 | 1.27% |
| DAX 40 | 18,748.18 | 213.62 | 1.15% |
| Dow JONES (US) | 40,000.90 | 247.15 | 0.62% |
| FTSE 100 | 8,252.91 | 29.57 | 0.36% |
| HKSE | 18,293.38 | 461.05 | 2.59% |
| NASDAQ | 18,398.45 | 115.04 | 0.63% |
| Nikkei 225 | 41,190.68 | 1,033.34 | -2.45% |
| NZX 50 Index | 12,134.97 | 76.68 | 0.64% |
| S&P 500 | 5,615.35 | 30.81 | 0.55% |
| S&P/ASX 200 | 7,959.30 | 69.70 | 0.88% |
| SSE Composite Index | 2,971.29 | 0.91 | 0.03% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 3.03% |
| Core Lithium Ltd CXO | 0.11 | 0.01 | 10.00% |
| Red 5 Ltd RED | 0.43 | 0.01 | 1.19% |
| Imugene Ltd IMU | 0.06 | 0.01 | 9.26% |
| Telstra Group Ltd TLS | 3.82 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 2.34 | 0.16 | 7.34% |
| Mirvac Group MGR | 2.01 | 0.08 | 4.15% |
| Latin Resources Ltd LRS | 0.17 | 0.00 | 0.00% |
| Melbana Energy Ltd MAY | 0.02 | 0.00 | -4.35% |
| Botanix Pharmaceuticals Ltd BOT | 0.38 | 0.06 | 16.92% |